WVE

Wave Life Sciences Ltd. - Ordinary Shares (WVE)

About Wave Life Sciences Ltd. - Ordinary Shares (WVE)

Wave Life Sciences Ltd. is a clinical-stage biotechnology company, which focuses on developing its proprietary RNA medicines platform and PRISM. It also develop and commercialize a pipeline RNA medicines in a variety of therapeutic areas. The company was founded by Gregory L. Verdine and Takeshi Wada on July 23, 2012 and is headquartered in Singapore.

Details

Daily high

$8.01

Daily low

$7.65

Price at open

$7.86

52 Week High

$16.74

52 Week Low

$5.04

Market cap

1.2B

Dividend yield

0.00%

Volume

1.4M

Avg. volume

1.2M

P/E ratio

-9.18

Wave Life Sciences Ltd. - Ordinary Shares News